4559
ZERIA PHARMACEUTICAL CO.,LTD.
ゼリア新薬工業
- Industry
- Pharmaceutical
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2021
55,442,073
Mar 2022
59,532,829
Mar 2023
68,383,227
Mar 2024
75,725,075
Mar 2025
87,311,137
Operating profit(thousand JPY)
Mar 2021
3,442,076
Mar 2022
6,366,058
Mar 2023
9,014,973
Mar 2024
9,621,647
Mar 2025
12,197,585
Operating profit margin(%)
Mar 2021
6.21
Mar 2022
10.69
Mar 2023
13.18
Mar 2024
12.71
Mar 2025
13.97
Profit before tax(thousand JPY)
Mar 2021
3,922,905
Mar 2022
5,721,764
Mar 2023
7,272,698
Mar 2024
9,508,394
Mar 2025
12,618,613
Profit(thousand JPY)
Mar 2021
3,119,785
Mar 2022
3,961,184
Mar 2023
6,195,865
Mar 2024
7,731,262
Mar 2025
9,936,323
Total assets(thousand JPY)
Mar 2021
121,859,337
Mar 2022
124,282,333
Mar 2023
135,034,536
Mar 2024
150,533,593
Mar 2025
159,171,596
Cash and cash equivalents(thousand JPY)
Mar 2021
9,668,938
Mar 2022
11,579,282
Mar 2023
16,094,078
Mar 2024
18,604,144
Mar 2025
23,467,676
Cash flows from operating activities(thousand JPY)
Mar 2021
6,894,290
Mar 2022
8,950,932
Mar 2023
13,157,415
Mar 2024
12,183,609
Mar 2025
12,922,046
Cash flows from investing activities(thousand JPY)
Mar 2021
-17,460,812
Mar 2022
-2,892,814
Mar 2023
-2,574,517
Mar 2024
-3,952,373
Mar 2025
-1,050,885
Cash flows from financing activities(thousand JPY)
Mar 2021
11,185,277
Mar 2022
-4,841,212
Mar 2023
-7,415,068
Mar 2024
-8,124,090
Mar 2025
-7,756,699
Return on equity(%)
Mar 2021
5.7
Mar 2022
7.1
Mar 2023
10.3
Mar 2024
10.7
Mar 2025
11.7
Equity ratio(%)
Mar 2021
46
Mar 2022
44.2
Mar 2023
48.5
Mar 2024
52.9
Mar 2025
56.3
Earnings per share(JPY per share)
Mar 2021
67.72
Mar 2022
87.76
Mar 2023
140.26
Mar 2024
175.39
Mar 2025
225.42
Net assets per share(JPY per share)
Mar 2021
1,225.69
Mar 2022
1,236.09
Mar 2023
1,484.79
Mar 2024
1,806.33
Mar 2025
2,031.33
Dividend per share(JPY per share)
Mar 2021
34
Mar 2022
35
Mar 2023
40
Mar 2024
44
Mar 2025
47
Payout ratio(%)
Mar 2021
50.21
Mar 2022
39.88
Mar 2023
28.52
Mar 2024
25.09
Mar 2025
20.85
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.